Correspondence 0001564590-23-006016 from MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313) (MAIA)
MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313)
Date: April 21, 2023 · CIK: 0001878313 · Accession: 0001564590-23-006016
AI Filing Summary & Sentiment
File numbers found in text: 333-269606
Letter
maia-corresp.htm
MAIA Biotechnology, Inc.
4444 West Lake Street, Suite 1700
Chicago, IL 60606
April 21, 2023
VIA EDGAR & TELECOPY
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Washington, D.C. 20549
Attention: Jimmy McNamara
RE:
MAIA Biotechnology, Inc. (the “Company”)
Registration Statement on Form S-1 (File No. 333-269606) (the “Registration Statement”)
Withdrawal Request for Acceleration of Effective Date
Ladies and Gentlemen:
Reference is made to the Company’s letter, filed as correspondence via EDGAR on April 18, 2023, in which the Company requested acceleration of effectiveness of the Registration Statement. The Company hereby formally withdraws its request for acceleration of the effective date pursuant to the prior letter.
Very truly yours,
MAIA Biotechnology, Inc.
Show Raw Text
CORRESP 1 filename1.htm maia-corresp.htm MAIA Biotechnology, Inc. 4444 West Lake Street, Suite 1700 Chicago, IL 60606 April 21, 2023 VIA EDGAR & TELECOPY U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Attention: Jimmy McNamara RE: MAIA Biotechnology, Inc. (the “Company”) Registration Statement on Form S-1 (File No. 333-269606) (the “Registration Statement”) Withdrawal Request for Acceleration of Effective Date Ladies and Gentlemen: Reference is made to the Company’s letter, filed as correspondence via EDGAR on April 18, 2023, in which the Company requested acceleration of effectiveness of the Registration Statement. The Company hereby formally withdraws its request for acceleration of the effective date pursuant to the prior letter. Very truly yours, MAIA Biotechnology, Inc. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer cc: Angela Dowd, Esq., Loeb & Loeb LLP